MedTrace Logo

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

NCT07116525 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-13

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and feasibility of the investigational catheter for mapping the atrial and ventricular regions of the heart.

Conditions

  • Scar-related Atrial Tachycardia
  • Persistent Atrial Fibrillation
  • Paroxysmal Atrial Fibrillation
  • Ventricular Procedures
  • Ventricular Tachycardia
  • Ischemic Ventricular Tachycardia
  • Non-ischemic Ventricular Tachycardia
  • Cardiomyopathy
  • Idiopathic Ventricular Tachycardia
  • Premature Ventricular Contraction

Interventions

DEVICE

Paddle-Shaped, High-Density, Multi-Electrode Mapping Catheter

High-density, multi-electrode mapping catheter will be used for the procedure.

Sponsors & Collaborators

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • Biosense Webster, Inc. Clinical Trial · Biosense Webster, Inc.

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2026-09-30
Completion
2026-09-30
FDA Device
Yes

Countries

  • Belgium
  • France
  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07116525 on ClinicalTrials.gov